RENAISSANCE TECHNOLOGIES LLC

Holdings History for Entrada Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TRDA)

Symbol: TRDA on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	-0.01%	$2,597,088	252,635	-341,665	-57%	$10.28	Q4 2025
30 Sep 2025	0%	+0%	$3,446,940	594,300	+214,800	+57%	$5.80	Q3 2025
30 Jun 2025	0%	+0%	$2,550,240	379,500	+51,015	+16%	$6.72	Q2 2025
31 Mar 2025	0%	+0%	$2,969,504	328,485	+162,285		$9.04	Q1 2025
31 Dec 2024	0%	+0%	$2,873,598	166,200	+72,400	+77%	$17.29	Q4 2024
30 Sep 2024	0%	+0%	$1,498,924	93,800	+49,200	+110%	$15.98	Q3 2024
30 Jun 2024	0%	+0%	$635,550	44,600	+44,600	NEW	$14.25	Q2 2024
30 Jun 2022		-0%	$0	0	-11,800	-100%	$11.30	Q2 2022
31 Mar 2022	0%	-0%	$111,000	11,800	-1,773	-13%	$9.41	Q1 2022
31 Dec 2021	0%	+0%	$232,000	13,573	+13,573	NEW	$17.09	Q4 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.